Market revenue in 2020 | USD 17.6 billion |
Market revenue in 2028 | USD 59.9 billion |
Growth rate | 16.6% (CAGR from 2020 to 2028) |
Largest segment | Detection kits |
Fastest growing segment | Detection Kits |
Historical data | 2018 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD billion |
Market segmentation | Purification Kits, Amplification Kits, Detection Kits, Isolation Kits |
Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, New England Biolabs, Illumina Inc, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, LGC Group, Toyobo Co Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biotechnology reagents & kits market will help companies and investors design strategic landscapes.
Detection kits was the largest segment with a revenue share of 22.73% in 2020. Horizon Databook has segmented the Canada biotechnology reagents & kits market based on purification kits, amplification kits, detection kits, isolation kits covering the revenue growth of each sub-segment from 2018 to 2028.
Canada is globally well positioned in the field of biotechnology and ranks second behind the U.S. in number of biotech firms in North America. Its advanced R&D infrastructure supports innovation, and the country has the second-highest concentration of biotechnology firms in North America.
These conditions include intellectual property protection & support, supportive tax regimes, regulatory efficiency, and supportive government programs, such as the Experimental Development Tax and Industrial Research Assistance Program.
Moreover, other important government initiatives and funding are Industrial Research Assistance Program, competitive corporate tax rate, federal venture capital, and fund of funds initiative. In addition, Canada has established the Canadian Biotechnology Strategy, which promotes the regulatory and research actions of various federal firms.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada biotechnology reagents & kits market , including forecasts for subscribers. This country databook contains high-level insights into Canada biotechnology reagents & kits market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account